The United States has a measles problem again, and it is the direct result of policy choices being made in Washington right now. The disease was declared eliminated here in 2000. It is now on the verge of returning to endemic status, and the federal government is actively weakening the tools that would stop it.
Consider what that means on the ground. Public health workers in outbreak states are now doing work that had mostly disappeared from American medicine a generation ago: confirming vaccination schedules for infants too young to be immunized, tracing genetic links between outbreaks hundreds of miles apart, and updating exposure protocols for diseases that were supposed to have been eliminated for good. None of it was expected to be routine again by 2026.
They are doing it because measles is the first vaccine-preventable disease to reappear when coverage drops. It is the canary. And ProPublica’s reporting lays out, in unusually direct terms, how quickly a functional public health system can be dismantled from the top.
The numbers tell the outline. Measles infections have surged in the U.S., with case counts reaching levels not seen in decades.
Measles is not a mild disease. It is among the most contagious pathogens known to medicine. Before the vaccine, it killed hundreds of American children a year and hospitalized tens of thousands.
The vaccine works. Two doses of MMR provide strong protection, and the shot has protected American children from measles, mumps and rubella for decades. That is the baseline. Everything else in this story is about what happens when the baseline is deliberately eroded.
Dr. Melinda Wharton, who spent decades leading CDC immunization programs, put it plainly in the ProPublica reporting: the current situation represents a worst-case scenario that even experienced public health officials struggled to imagine. That sentence is worth sitting with. It comes from someone who spent her career modeling exactly these scenarios.
The federal posture on vaccines has shifted in ways that are not subtle. In August, the administration issued an executive order restructuring how childhood vaccine recommendations are set. The government’s promotional stance on immunization — decades of bipartisan consensus, from Reagan through Biden — has been openly abandoned.
The more consequential move is quieter. The administration is reportedly considering changes to the Vaccine Injury Compensation Program, the federal system that shields manufacturers from most tort liability in exchange for a no-fault compensation fund for injuries. Weaken that shield, and the economics of producing childhood vaccines in the United States change quickly. Manufacturers have narrow margins on these products. Several have already exited adjacent markets over liability exposure.
Stanford epidemiologists Mathew Kiang and Nathan Lo modeled what would happen if vaccines for polio, measles, rubella or diphtheria were no longer available in the U.S. Their work, summarized in ProPublica’s companion feature on childhood vaccine access, projects a death toll running into the hundreds of thousands over 25 years under the most severe scenario — measles deaths alone average close to 290,000 in the model. Polio is the one that reads hardest. Modern medicine, as the ProPublica author noted, cannot reverse paralysis from polio.
Consider the healthcare workers now dealing with this reality: a labor and delivery nurse in Amarillo who has seen measles admissions in the pediatric wing where she works, or a retired county health officer in western Kentucky who spent his career on the assumption that eradicated diseases stayed eradicated. Both of them are working inside a system whose central premise — that the federal government will publicly back the vaccine schedule — is no longer intact.
That premise mattered more than most people realized. Public trust in childhood immunization was built through consistent, boring, repeated official endorsement across administrations. When the endorsement disappears, the schedule does not collapse overnight. It frays at the edges — a delayed second dose here, a religious exemption there, a county where kindergarten coverage drops from 95 percent to 88 percent.
Measles finds those edges immediately. The disease requires high community coverage to prevent sustained transmission. The math is unforgiving. A five-point drop in a small county is enough to sustain an outbreak for months.
The most alarming detail in the ProPublica reporting is not the case count. It is what the CDC did with its own risk assessment. At the beginning of the second Trump administration, agency leadership ordered staff not to release an assessment finding high measles risk in areas with low vaccination rates. The public did not see the warning.
That is the kind of decision that changes what a public health agency is. The CDC’s core function is to tell Americans what it knows about disease risk. Withholding an internal risk assessment from the public because it contradicts the administration’s political posture is a different institution than the one that existed in 2019.
ProPublica’s genomic work — its analysis of the viral code from the Utah and Texas outbreaks — showed the strains were linked, meaning transmission chains crossed state lines undetected for a period. That is the practical cost of a slower, quieter federal response. States lose the early warning that would let them contain an outbreak before it becomes multi-state.
The pattern here is familiar to anyone who has watched institutional erosion in other domains. Policy events tend to outlast the political moment that produced them, and structural changes made under one administration set the operating conditions for the next. Vaccine infrastructure operates the same way. Manufacturer exits, program changes, and agency norms, once broken, do not snap back when the political weather shifts.
According to a ProPublica report, a German hospital doctor who treated an unvaccinated boy who died of diphtheria noted that such diseases had become so rare they were considered matters of historical interest in medical education rather than current clinical practice. That is the sentence that captures what is at stake. Diseases become historical in medical education because the vaccine schedule holds. When it stops holding, they become clinical again.
Consider parents whose children cannot be vaccinated due to medical conditions. Their protection has always come from the fact that everyone around them is. That is the actual mechanism of herd immunity — it is a favor the vaccinated do for the small number of people who cannot be. When coverage drops, it drops for them first.
The debate over vaccine policy is often framed as a debate about individual choice. The framing obscures the mechanism. Vaccines are one of the few interventions in medicine whose effectiveness depends on collective participation. That is what makes federal endorsement structurally different from federal endorsement of, say, a particular diet. The endorsement is the intervention, or a large part of it.
What the ProPublica reporting establishes, carefully and with named sources, is that the current federal posture is not neutral on this question. It is actively producing conditions under which coverage falls, outbreaks spread further before detection, and manufacturers face incentives to exit the market entirely. Each of those is reversible. All three together, sustained for several years, may not be.
Measles was in the rearview mirror because a specific set of institutions did specific work, decade after decade, without much public notice. That work is being undone in public, on the record, with the case counts to match. The disease is doing exactly what the epidemiologists said it would do when the scaffolding came down.